Watchlist Price Alert

Karuna Therapeutics Inc. (KRTX)

NASDAQ: KRTX · Real-Time Price · USD

329.83

0.09 (0.03%)

At close: Mar 15, 2024, 8:00 PM

Karuna Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-433.68M	-276.34M	-143.81M	-68.55M	-43.96M	-17.51M	-6.03M
Depreciation & Amortization	1.7M	1.11M	506K	145K	58K	6K	1K
Stock-Based Compensation	74.6M	47.45M	29.81M	13.47M	12.57M	958K	215K
Other Working Capital	5.12M	2.84M	11.52M	-15.9M	321K	-1.33M	26K
Other Non-Cash Items	-37.97M	-5.01M	1.76M	662K	-326K	2.58M	1.17M
Deferred Income Tax	n/a	n/a	n/a	n/a	135K	444K	55K
Change in Working Capital	9.53M	4.77M	10.85M	-15.58M	599K	-1.86M	563K
Operating Cash Flow	-385.82M	-228.01M	-100.88M	-69.86M	-30.92M	-15.38M	-4.03M
Capital Expenditures	-2.92M	-915K	-3.07M	-419K	-115K	-132K	-13K
Cash Acquisitions	3.92M	1.22M	3.15M	419K	115K	n/a	n/a
Purchase of Investments	-1.52B	-930.28M	-400.83M	-344.21M	-231.72M	-4.98M	n/a
Sales Maturities Of Investments	1.36B	344.8M	381.21M	254.98M	57.5M	n/a	n/a
Other Investing Acitivies	-3.92M	-1.22M	-3.15M	-419K	-115K	n/a	n/a
Investing Cash Flow	-160.32M	-586.39M	-22.69M	-89.65M	-174.34M	-5.12M	-13K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	483.37M	855.78M	277.57M	3.66M	405.28M	27.58M	4.25M
Financial Cash Flow	483.37M	855.78M	277.57M	3.66M	405.28M	27.58M	4.25M
Net Cash Flow	-62.77M	41.38M	154.01M	-155.85M	200.03M	7.08M	210K
Free Cash Flow	-388.74M	-228.92M	-103.95M	-70.28M	-31.04M	-15.51M	-4.04M